New York Life Investment Management’s Insmed INSM Stock Holding History

New York Life Investment Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$527K	Buy	4,942 +992	+25%	+$120K	﹤0.01%	748
2026 Q1	$646K	Buy	3,950 +2,689	+213%	+$413K	0.01%	734
2025 Q4	$219K	Sell	1,261 -17,916	-93%	-$3.27M	﹤0.01%	762
2025 Q3	$2.76M	Buy	19,177 +497	+3%	+$60.9K	0.02%	472
2025 Q2	$1.88M	Sell	18,680 -124	-0.7%	-$9.48K	0.02%	546
2025 Q1	$1.43M	Buy	18,804 +929	+5%	+$71.1K	0.01%	593
2024 Q4	$1.23M	Sell	17,875 -469	-3%	-$33.8K	0.01%	625
2024 Q3	$1.34M	Buy	+18,344	New	+$1.35M	0.01%	641

Other funds holding INSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

New York Life Investment Management's INSM Position: Q2 2026 in Review

New York Life Investment Management increased its Insmed (INSM) stake by 25% in Q2 2026, buying an estimated $120K and bringing the position to 4,942 shares worth $527K. The position accounts for ﹤0.01% of the portfolio, ranked #748.

New York Life Investment Management first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.76M in Q3 2025. 387 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

New York Life Investment Management held 4,942 shares of Insmed worth $527K as of Q2 2026.
New York Life Investment Management bought 992 Insmed shares in Q2 2026, an estimated $120K.
Insmed made up ﹤0.01% of New York Life Investment Management's portfolio in Q2 2026, its #748 holding.
New York Life Investment Management first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
New York Life Investment Management's Insmed position peaked at $2.76M in Q3 2025.
387 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.